Conference item icon

Conference item

Long-term efficacy of sulfonylureas: a United Kingdom Prospective Diabetes Study perspective.

Abstract:

The United Kingdom Prospective Diabetes Study shows sulfonylureas to be an effective first-line therapy for people with type 2 diabetes mellitus. The durability of the glycemic control obtained is dependent on the degree to which beta-cell function can be maintained, but sulfonylureas appear neither to increase nor to decrease the underlying rate of loss of beta-cell function. As sulfonylureas act by enhancing insulin secretion, they are probably best used close to the time when diabetes is d...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
RDM
Sub department:
OCDEM
Role:
Author
Journal:
Metabolism: clinical and experimental
Volume:
55
Issue:
5 Suppl 1
Pages:
S2-S5
Publication date:
2006-05-01
Event title:
Symposium on Sulfonylureas in the Therapy of Type 2 Diabetes held at the 41st Annual Meeting of the European-Association-for-the-Study-of-Diabetes
DOI:
EISSN:
1532-8600
ISSN:
0026-0495
Source identifiers:
10354

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP